{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:27:35Z","timestamp":1785421655976,"version":"3.56.0"},"reference-count":44,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24DZ2202900"],"award-info":[{"award-number":["24DZ2202900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"award":["24DZ2202900"],"award-info":[{"award-number":["24DZ2202900"]}],"id":[{"id":"https:\/\/ror.org\/03kt66j61","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Prostate cancer remains a significant global health burden, yet current diagnostic reliance on PSA screening is heavily hampered by limited specificity and high rates of overdiagnosis. Methods: To address this clinical bottleneck, we utilized a highly sensitive Complete360\u00ae-MyMeta targeted-metabolomics platform to perform high-resolution profiling of 43 metabolites across the carnitine, polyamine, and methylation networks in plasma from a discovery cohort of all-stage (I\u2013IV) PCa patients and healthy controls. Results: Our analysis identified 28 significantly altered metabolites (p &lt; 0.05), revealing profound systemic metabolic reprogramming characterized by the depletion of circulating TML and putrescine, alongside the elevation of L-acetylcarnitine and sarcosine. These systemic shifts are consistent with a localized tumoral \u201cmetabolic sink\u201d, wherein upregulated mitochondrial TML import via the SLC25A45 transporter actively fuels fatty acid oxidation, while parallel androgen signaling drives massive polyamine synthesis. Translating these mechanistic insights into a clinical tool, we developed a multivariable diagnostic signature utilizing mathematically stable bipartite metabolic ratios. An optimized, cross-validated model combining L-acetylcarnitine\/TML and sarcosine\/putrescine effectively mitigated physiological noise to achieve robust diagnostic separation, yielding an area under the curve (AUC) of 0.99. Conclusions: Ultimately, this study provides a discovery-phase proof-of-concept for the SLC25A45-TML axis as a mechanistically grounded, stage-independent liquid biopsy, offering a rational, non-invasive framework to significantly improve PCa detection.<\/jats:p>","DOI":"10.3390\/cancers18101571","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:33:37Z","timestamp":1778589217000},"page":"1571","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The SLC25A45-TML Axis as a Biological Foundation for a Multivariable Plasma Metabolite Signature for High-Precision Prostate Cancer Detection"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-6778","authenticated-orcid":false,"given":"Liang","family":"Zhao","sequence":"first","affiliation":[{"name":"Complete Omics Inc., Baltimore, MD 21227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8081-253X","authenticated-orcid":false,"given":"Raghothama","family":"Chaerkady","sequence":"additional","affiliation":[{"name":"Complete Omics Inc., Baltimore, MD 21227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseruddin","family":"H\u00f6ti","sequence":"additional","affiliation":[{"name":"Complete Omics Inc., Baltimore, MD 21227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Zhao","sequence":"additional","affiliation":[{"name":"Gilman School, Baltimore, MD 21210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Complete Omics Inc., Baltimore, MD 21227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Fair","sequence":"additional","affiliation":[{"name":"Complete Omics Inc., Baltimore, MD 21227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-766X","authenticated-orcid":false,"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Complete Omics Inc., Baltimore, MD 21227, USA"},{"name":"Complete Omics (Hangzhou) Inc., Hangzhou 311200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5942-1204","authenticated-orcid":false,"given":"Xiaonan","family":"Kang","sequence":"additional","affiliation":[{"name":"Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: An Updated Comprehensive Online ADMET Prediction Platform Enhanced with Broader Coverage, Improved Performance, API Functionality and Decision Support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality Results from a Randomized Prostate-Cancer Screening Trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Preventive Services Task Force* Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc2351","article-title":"Prostate-Specific Antigen and Prostate Cancer: Prediction, Detection and Monitoring","volume":"8","author":"Lilja","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and Overtreatment of Prostate Cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-Specific Antigen\u2013Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MED.0b013e328360332a","article-title":"Prostate Cancer Overdiagnosis and Overtreatment","volume":"20","author":"Klotz","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic Accuracy of Multi-Parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic Review of Complications of Prostate Biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Eidelman, E., Twum-Ampofo, J., Ansari, J., and Siddiqui, M.M. (2017). The Metabolic Phenotype of Prostate Cancer. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00131"},{"key":"ref_13","first-page":"1518","article-title":"The Fat Side of Prostate Cancer","volume":"1831","author":"Zadra","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, C.-L., Lin, C.-Y., and Kung, H.-J. (2021). Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413435"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"61890","DOI":"10.18632\/oncotarget.11301","article-title":"Metabolic Shift toward Oxidative Phosphorylation in Docetaxel Resistant Prostate Cancer Cells","volume":"7","author":"Ippolito","year":"2016","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer Metabolism: Fatty Acid Oxidation in the Limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41585-020-0288-x","article-title":"Tumour Metabolism and Its Unique Properties in Prostate Adenocarcinoma","volume":"17","author":"Bader","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1535-7163.MCT-14-0183","article-title":"Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer","volume":"13","author":"Schlaepfer","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41419-018-0313-7","article-title":"The Carnitine System and Cancer Metabolic Plasticity","volume":"9","author":"Melone","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.molcel.2025.08.018","article-title":"SLC25A45 Is Required for Mitochondrial Uptake of Methylated Amino Acids and de Novo Carnitine Biosynthesis","volume":"85","author":"Dias","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kumar, R., Jonnatan, S., Sanin, D.E., Vakkala, V., Kadam, A., Kumar, S., Dalrymple, S.L., Zhao, L., Foley, J., and Holbert, C.E. (2024). Androgen Receptor Drives Polyamine Synthesis Creating a Vulnerability for Prostate Cancer. medRxiv.","DOI":"10.1101\/2024.12.12.24318845"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Corbin, J., and Ruiz-Echevarr\u00eda, M. (2016). One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081208"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/CCO.0000000000001134","article-title":"Polyamine Metabolism in Prostate Cancer","volume":"37","author":"Sena","year":"2025","journal-title":"Curr. Opin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine Metabolism and Cancer: Treatments, Challenges and Opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic Profiles Delineate Potential Role for Sarcosine in Prostate Cancer Progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"key":"ref_26","first-page":"63","article-title":"Pseudouridine as a Novel Biomarker in Prostate Cancer","volume":"39","author":"Stockert","year":"2021","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jat.2874","article-title":"Review: Toxicometabolomics","volume":"33","author":"Bouhifd","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: Beyond Biomarkers and towards Mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_29","first-page":"333","article-title":"Metabolomics in Cancer Research and Emerging Applications in Clinical Oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-017-0130-7","article-title":"Promises and Pitfalls of Untargeted Metabolomics","volume":"41","author":"Gertsman","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-biochem-061516-044952","article-title":"Metabolite Measurement: Pitfalls to Avoid and Practices to Follow","volume":"86","author":"Lu","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ribbenstedt, A., Ziarrusta, H., and Benskin, J.P. (2018). Development, Characterization and Comparisons of Targeted and Non-Targeted Metabolomics Methods. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207082"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating Characteristics of Prostate-Specific Antigen in Men with an Initial PSA Level of 3.0 Ng\/mL or Lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Merriel, S.W.D., Pocock, L., Gilbert, E., Creavin, S., Walter, F.M., Spencer, A., and Hamilton, W. (2022). Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Prostate-Specific Antigen (PSA) for the Detection of Prostate Cancer in Symptomatic Patients. BMC Med., 20.","DOI":"10.1186\/s12916-021-02230-y"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chaerkady, R., Zhao, L., Kashyap, A., Fair, M., and Wang, Q. (2025). Complete360: A Multi-Omics Liquid Biopsy Platform with Attomole Sensitivity and High Reproducibility. Bioxiv.","DOI":"10.1101\/2025.05.16.654403"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: Towards a Unified Platform for Metabolomics Data Processing, Analysis and Interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/pros.22704","article-title":"Metabolomic Signatures of Aggressive Prostate Cancer","volume":"73","author":"McDunn","year":"2013","journal-title":"Prostate"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11306-018-1367-3","article-title":"Guidelines and Considerations for the Use of System Suitability and Quality Control Samples in Mass Spectrometry Assays Applied in Untargeted Clinical Metabolomic Studies","volume":"14","author":"Broadhurst","year":"2018","journal-title":"Metabolomics"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Anton, G., Wilson, R., Yu, Z., Prehn, C., Zukunft, S., Adamski, J., Heier, M., Meisinger, C., R\u00f6misch-Margl, W., and Wang-Sattler, R. (2015). Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121495"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10354","article-title":"Human Metabolic Individuality in Biomedical and Pharmaceutical Research","volume":"477","author":"CARDIoGRAM","year":"2011","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1021\/acs.analchem.0c00338","article-title":"Reference Standardization for Quantification and Harmonization of Large-Scale Metabolomics","volume":"92","author":"Liu","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1055-9965.EPI-15-1223","article-title":"Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence","volume":"25","author":"Kelly","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials","volume":"74","author":"Dambrova","year":"2022","journal-title":"Pharmacol. Rev."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/10\/1571\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:11:24Z","timestamp":1779250284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/10\/1571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18101571"],"URL":"https:\/\/doi.org\/10.3390\/cancers18101571","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}